Selected research
Industry Growth & Trends
Global Organ Tumor Chip Industry Growth and Trends Forecast to 2032
Market perspective
The global Organ Tumor Chip market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Organ Tumor Chip is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Organ Tumor Chip is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Organ Tumor Chip is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Organ Tumor Chip include Axosim Technologies, Beonchip, BioIVT, Emulate, InSphero AG, Mimetas, Nortis and Organovo Holdings, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Organ Tumor Chip market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Organ Tumor Chip market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Organ Tumor Chip market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Organ Tumor Chip.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Organ Tumor Chip market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Organ Tumor Chip Market by Company
Axosim Technologies
Beonchip
BioIVT
Emulate
InSphero AG
Mimetas
Nortis
Organovo Holdings
Organ Tumor Chip Segment by Type
Lung Tumor-on-a-chip
Bone Marrow Tumor-on-a-chip
Brain Tumor-on-a-chip
Breast Tumor-on-a-chip
Urinary System Tumor-on-a-chip
Intestine Tumor-on-a-chip
Liver Tumor-on-a-chip
Organ Tumor Chip Segment by Application
Hospital
Laboratory
Organ Tumor Chip Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Organ Tumor Chip market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Organ Tumor Chip and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Organ Tumor Chip.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Organ Tumor Chip manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Organ Tumor Chip in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Lung Tumor-on-a-chip
- Bone Marrow Tumor-on-a-chip
- Brain Tumor-on-a-chip
- Breast Tumor-on-a-chip
- Urinary System Tumor-on-a-chip
- Intestine Tumor-on-a-chip
- Liver Tumor-on-a-chip
Applications
- Hospital
- Laboratory
Companies covered
- Axosim Technologies
- Beonchip
- BioIVT
- Emulate
- InSphero AG
- Mimetas
- Nortis
- Organovo Holdings
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Organ Tumor Chip Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Organ Tumor Chip Sales Estimates and Forecasts (2021-2032)
- 1.3 Organ Tumor Chip Market by Type
- 1.3.1 Lung Tumor-on-a-chip
- 1.3.2 Bone Marrow Tumor-on-a-chip
- 1.3.3 Brain Tumor-on-a-chip
- 1.3.4 Breast Tumor-on-a-chip
- 1.3.5 Urinary System Tumor-on-a-chip
- 1.3.6 Intestine Tumor-on-a-chip
- 1.3.7 Liver Tumor-on-a-chip
- 1.4 Global Organ Tumor Chip Market Size by Type
- 1.4.1 Global Organ Tumor Chip Market Size Overview by Type (2021-2032)
- 1.4.2 Global Organ Tumor Chip Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Organ Tumor Chip Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Organ Tumor Chip Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Organ Tumor Chip Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Organ Tumor Chip Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Organ Tumor Chip Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Organ Tumor Chip Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Organ Tumor Chip Industry Trends
- 2.2 Organ Tumor Chip Industry Drivers
- 2.3 Organ Tumor Chip Industry Opportunities and Challenges
- 2.4 Organ Tumor Chip Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Organ Tumor Chip Revenue (2021-2026)
- 3.2 Global Top Players by Organ Tumor Chip Sales (2021-2026)
- 3.3 Global Top Players by Organ Tumor Chip Price (2021-2026)
- 3.4 Global Organ Tumor Chip Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Organ Tumor Chip Major Company Production Sites & Headquarters
- 3.6 Global Organ Tumor Chip Company, Product Type & Application
- 3.7 Global Organ Tumor Chip Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Organ Tumor Chip Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Organ Tumor Chip Players Market Share by Revenue in 2025
- 3.8.3 2025 Organ Tumor Chip Tier 1, Tier 2, and Tier 3
4 Organ Tumor Chip Regional Status and Outlook
- 4.1 Global Organ Tumor Chip Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Organ Tumor Chip Historic Market Size by Region
- 4.2.1 Global Organ Tumor Chip Sales in Volume by Region (2021-2026)
- 4.2.2 Global Organ Tumor Chip Sales in Value by Region (2021-2026)
- 4.2.3 Global Organ Tumor Chip Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Organ Tumor Chip Forecasted Market Size by Region
- 4.3.1 Global Organ Tumor Chip Sales in Volume by Region (2027-2032)
- 4.3.2 Global Organ Tumor Chip Sales in Value by Region (2027-2032)
- 4.3.3 Global Organ Tumor Chip Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Organ Tumor Chip by Application
- 5.1 Organ Tumor Chip Market by Application
- 5.1.1 Hospital
- 5.1.2 Laboratory
- 5.2 Global Organ Tumor Chip Market Size by Application
- 5.2.1 Global Organ Tumor Chip Market Size Overview by Application (2021-2032)
- 5.2.2 Global Organ Tumor Chip Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Organ Tumor Chip Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Organ Tumor Chip Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Organ Tumor Chip Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Organ Tumor Chip Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Organ Tumor Chip Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Organ Tumor Chip Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Axosim Technologies
- 6.1.1 Axosim Technologies Company Information
- 6.1.2 Axosim Technologies Business Overview
- 6.1.3 Axosim Technologies Organ Tumor Chip Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Axosim Technologies Organ Tumor Chip Product Portfolio
- 6.1.5 Axosim Technologies Recent Developments
- 6.2 Beonchip
- 6.2.1 Beonchip Company Information
- 6.2.2 Beonchip Business Overview
- 6.2.3 Beonchip Organ Tumor Chip Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Beonchip Organ Tumor Chip Product Portfolio
- 6.2.5 Beonchip Recent Developments
- 6.3 BioIVT
- 6.3.1 BioIVT Company Information
- 6.3.2 BioIVT Business Overview
- 6.3.3 BioIVT Organ Tumor Chip Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 BioIVT Organ Tumor Chip Product Portfolio
- 6.3.5 BioIVT Recent Developments
- 6.4 Emulate
- 6.4.1 Emulate Company Information
- 6.4.2 Emulate Business Overview
- 6.4.3 Emulate Organ Tumor Chip Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Emulate Organ Tumor Chip Product Portfolio
- 6.4.5 Emulate Recent Developments
- 6.5 InSphero AG
- 6.5.1 InSphero AG Company Information
- 6.5.2 InSphero AG Business Overview
- 6.5.3 InSphero AG Organ Tumor Chip Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 InSphero AG Organ Tumor Chip Product Portfolio
- 6.5.5 InSphero AG Recent Developments
- 6.6 Mimetas
- 6.6.1 Mimetas Company Information
- 6.6.2 Mimetas Business Overview
- 6.6.3 Mimetas Organ Tumor Chip Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Mimetas Organ Tumor Chip Product Portfolio
- 6.6.5 Mimetas Recent Developments
- 6.7 Nortis
- 6.7.1 Nortis Company Information
- 6.7.2 Nortis Business Overview
- 6.7.3 Nortis Organ Tumor Chip Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Nortis Organ Tumor Chip Product Portfolio
- 6.7.5 Nortis Recent Developments
- 6.8 Organovo Holdings
- 6.8.1 Organovo Holdings Company Information
- 6.8.2 Organovo Holdings Business Overview
- 6.8.3 Organovo Holdings Organ Tumor Chip Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Organovo Holdings Organ Tumor Chip Product Portfolio
- 6.8.5 Organovo Holdings Recent Developments
7 North America by Country
- 7.1 North America Organ Tumor Chip Sales by Country
- 7.1.1 North America Organ Tumor Chip Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Organ Tumor Chip Sales by Country (2021-2026)
- 7.1.3 North America Organ Tumor Chip Sales Forecast by Country (2027-2032)
- 7.2 North America Organ Tumor Chip Market Size by Country
- 7.2.1 North America Organ Tumor Chip Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Organ Tumor Chip Market Size by Country (2021-2026)
- 7.2.3 North America Organ Tumor Chip Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Organ Tumor Chip Sales by Country
- 8.1.1 Europe Organ Tumor Chip Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Organ Tumor Chip Sales by Country (2021-2026)
- 8.1.3 Europe Organ Tumor Chip Sales Forecast by Country (2027-2032)
- 8.2 Europe Organ Tumor Chip Market Size by Country
- 8.2.1 Europe Organ Tumor Chip Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Organ Tumor Chip Market Size by Country (2021-2026)
- 8.2.3 Europe Organ Tumor Chip Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Organ Tumor Chip Sales by Country
- 9.1.1 Asia-Pacific Organ Tumor Chip Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Organ Tumor Chip Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Organ Tumor Chip Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Organ Tumor Chip Market Size by Country
- 9.2.1 Asia-Pacific Organ Tumor Chip Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Organ Tumor Chip Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Organ Tumor Chip Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Organ Tumor Chip Sales by Country
- 10.1.1 South America Organ Tumor Chip Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Organ Tumor Chip Sales by Country (2021-2026)
- 10.1.3 South America Organ Tumor Chip Sales Forecast by Country (2027-2032)
- 10.2 South America Organ Tumor Chip Market Size by Country
- 10.2.1 South America Organ Tumor Chip Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Organ Tumor Chip Market Size by Country (2021-2026)
- 10.2.3 South America Organ Tumor Chip Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Organ Tumor Chip Sales by Country
- 11.1.1 Middle East and Africa Organ Tumor Chip Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Organ Tumor Chip Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Organ Tumor Chip Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Organ Tumor Chip Market Size by Country
- 11.2.1 Middle East and Africa Organ Tumor Chip Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Organ Tumor Chip Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Organ Tumor Chip Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Organ Tumor Chip Value Chain Analysis
- 12.1.1 Organ Tumor Chip Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Organ Tumor Chip Production Mode & Process
- 12.2 Organ Tumor Chip Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Organ Tumor Chip Distributors
- 12.2.3 Organ Tumor Chip Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst